NYSE · Medical - Devices

AORT (AORT) Stock

$27.12 +2.07% NYSE: AORT Healthcare

Valuation

MetricValue
Price$27.12
Market Cap$1.32B
P/E Ratio108.24
P/B Ratio2.46
P/S Ratio2.37
EPS (TTM)$0.00
52-Week High$48.25
52-Week Low$20.13
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE2.23%
ROA1.13%
ROCE6.03%
Gross Margin5.90%
Operating Margin6.12%
Net Margin2.55%
Debt/Equity0.57
Current Ratio2.98

Annual Financials (USD)

Metric20212022202320242025
Revenue$299.0M$314.0M$354.0M$389.0M$441.0M
Operating Profit$8.0M$6.0M$6.0M$39.0M$27.0M
Net Profit$-15.0M$-19.0M$-31.0M$-13.0M$10.0M
EPS$-0.38$-0.48$-0.75$-0.32$0.21
Op Margin2.7%2.0%1.6%10.0%6.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$793.0M$763.0M$792.0M$789.0M$885.0M
Total Liabilities$492.0M$478.0M$511.0M$513.0M$437.0M
Cash$55.0M$39.0M$59.0M$53.0M$65.0M
Borrowings$362.0M$357.0M$358.0M$362.0M$292.0M

Latest News

Hazardous Canadian wildfire smoke choking millions in US AFP · Jul 16, 2026 JPMorgan has blunt response to MicroStrategy's cash reserve boost TheStreet · Jul 16, 2026 Why Newell Brands Stock Raced More Than 5% Higher Today Motley Fool · Jul 16, 2026 Erbil’s Oldest Quarter Becomes Home to the Kurdistan Region’s First Cultural District GlobeNewswire · Jul 16, 2026 Brandes Investment Partners Supports NLB Offer for Addiko Shares PR Newswire · Jul 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-5.0M$19.0M$22.0M$38.0M
Investing Cash Flow$-7.0M$-21.0M$-8.0M$-39.0M$-81.0M
Financing Cash Flow$-9.0M$1.0M$4.0M$-3.0M$2.0M
Net Cash Flow$-7.0M$-16.0M$20.0M$-5.0M$11.0M
Free Cash Flow$-16.0M$-16.0M$11.0M$11.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA27.15
FCF Yield1.18%
Quick Ratio2.22
Interest Coverage1.00
Return 1Y-19.97%
Return 3Y48.90%
Return 5Y-10.56%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADUS $116.46 +2.46% 17.77 $2.17B 0.00%
ARDT $10.73 -1.83% 10.45 $1.54B 0.00%
BKDBrookdale Senior Living Inc. $15.55 +2.61% -17.64 $3.71B 0.00%
COGT $42.27 -1.33% -34.70 $7.22B 0.00%
INSP $50.93 +3.54% 8.73 $1.47B 0.00%

About AORT

AORT is led by CEO James Patrick Mackin, employs 1,600 people, headquartered in US, publicly traded since 1993.

AORT stock trades at $27.12 with a market capitalization of $1.32B. The stock is valued at a price-to-earnings (P/E) ratio of 108.24, price-to-book of 2.46, price-to-sales of 2.37. Over the past 52 weeks the stock has ranged between $20.13 and $48.25, and currently trades 43.8% below its 52-week high.

On profitability, AORT generates a return on equity (ROE) of 2.23%, return on capital employed of 6.03%, an operating margin of 6.12%, a net profit margin of 2.55%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides